In the News: Rho Granted Extension by NIAID to Study Rate of COVID-19 Infection in US Children
The Human Epidemiology and Response to SARS-CoV-2 (HEROS) study that aims to help determine the rate of the new coronavirus infection in children and their families in the U.S. has been extended through April 2022.
Check out the full articles below to see what the goals are for the study in year two:
American Pharmaceutical Review